Healthcare Sector Stocks
The Healthcare sector has a total of 1045 stocks, with a combined market cap of $9.28 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.14.
Market Cap
9.28T
Revenue
4.66T
Profits
188.81B
PE Ratio
49.14
Profit Margin
4.05%
Dividend Yield
0.39%
1045 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | 0.13% | 1,925,146 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 653.61B | 0.20% | 4,085,941 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 467.12B | -0.29% | 2,541,396 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 367.07B | 0.54% | 8,290,251 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 338.03B | 0.42% | 4,078,506 | 450.53B |
| 6 | NVS | Novartis AG | 274.75B | 1.32% | 1,165,722 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 257.77B | 1.23% | 2,067,865 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 249.58B | -0.50% | 2,097,555 | 46.34B |
| 9 | AMGN | Amgen Inc. | 224.15B | 2.11% | 2,213,255 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 187.15B | 0.83% | 5,284,277 | 30.46B |
| 11 | ABT | Abbott Laboratories | 175.27B | 0.22% | 7,785,059 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 170.60B | 0.47% | 10,184,052 | 50.34B |
| 13 | PFE | Pfizer Inc. | 163.41B | 0.92% | 27,763,665 | 63.70B |
| 14 | DHR | Danaher Corporation | 157.81B | 0.32% | 4,423,643 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 143.14B | 1.42% | 2,496,484 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 133.37B | 0.73% | 756,167 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.41B | 2.21% | 10,673,288 | 49.19B |
| 18 | CVS | CVS Health Corporation | 113.99B | 4.80% | 15,768,106 | 412.65B |
| 19 | MDT | Medtronic plc | 113.38B | 0.97% | 13,250,393 | 37.54B |
| 20 | SYK | Stryker Corporation | 104.47B | 0.97% | 2,337,205 | 25.84B |
| 21 | MCK | McKesson Corporation | 101.04B | -0.31% | 452,045 | 410.98B |
| 22 | GSK | GSK plc | 98.20B | -0.83% | 3,324,158 | 44.05B |
| 23 | SNY | Sanofi | 98.02B | 0.42% | 2,216,920 | 55.89B |
| 24 | HCA | HCA Healthcare, Inc. | 94.31B | 2.86% | 1,020,236 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 85.90B | -0.54% | 1,219,207 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 79.40B | 2.08% | 13,963,886 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 78.69B | -1.00% | 592,145 | 15.53B |
| 28 | CI | The Cigna Group | 71.88B | 2.45% | 1,821,866 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 63.65B | -1.70% | 15,208,283 | 21.00B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 60.57B | 1.45% | 2,737,923 | 28.42B |
| 31 | ARGX | argenx SE | 60.24B | -0.28% | 264,371 | 5.32B |
| 32 | NTRA | Natera, Inc. | 59.47B | 0.92% | 1,612,839 | 2.71B |
| 33 | COR | Cencora, Inc. | 58.57B | -0.95% | 1,084,053 | 332.77B |
| 34 | CAH | Cardinal Health, Inc. | 50.99B | -1.08% | 2,092,884 | 254.25B |
| 35 | BDX | Becton, Dickinson and Company | 50.07B | 2.56% | 1,472,837 | 22.48B |
| 36 | EW | Edwards Lifesciences Corporation | 49.74B | 0.65% | 3,599,767 | 6.51B |
| 37 | A | Agilent Technologies, Inc. | 48.71B | -0.03% | 2,582,118 | 7.37B |
| 38 | HUM | Humana Inc. | 47.78B | 4.63% | 1,938,476 | 145.68B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 45.67B | -2.56% | 3,874,734 | 17.32B |
| 40 | MDLN | Medline Inc. | 45.62B | 0.12% | 7,797,834 | 29.94B |
| 41 | VEEV | Veeva Systems Inc. | 45.44B | 2.12% | 1,735,951 | 3.46B |
| 42 | IQV | IQVIA Holdings Inc. | 44.50B | -1.69% | 1,104,705 | 16.98B |
| 43 | RVMD | Revolution Medicines, Inc. | 43.93B | 2.56% | 2,520,486 | - |
| 44 | WAT | Waters Corporation | 42.59B | 0.75% | 662,535 | 4.64B |
| 45 | ONC | BeOne Medicines AG | 41.03B | 0.24% | 377,176 | 6.13B |
| 46 | IDXX | IDEXX Laboratories, Inc. | 40.91B | 1.14% | 331,112 | 4.55B |
| 47 | ILMN | Illumina, Inc. | 40.77B | -1.42% | 5,031,977 | 4.49B |
| 48 | HLN | Haleon plc | 39.97B | 0.43% | 22,366,229 | 14.80B |
| 49 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.25B | 2.55% | 1,084,464 | 4.80B |
| 50 | BIIB | Biogen Inc. | 33.63B | 0.55% | 957,974 | 10.03B |
| 51 | RPRX | Royalty Pharma plc | 33.47B | -0.14% | 1,869,475 | 2.54B |
| 52 | DXCM | DexCom, Inc. | 32.69B | -0.97% | 1,875,538 | 4.97B |
| 53 | RMD | ResMed Inc. | 31.76B | 0.05% | 760,794 | 5.65B |
| 54 | ALC | Alcon Inc. | 31.09B | -0.14% | 2,457,877 | 10.86B |
| 55 | CNC | Centene Corporation | 30.54B | -0.16% | 3,630,919 | 180.30B |
| 56 | MTD | Mettler-Toledo International Inc. | 30.29B | -0.49% | 129,644 | 4.13B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 30.10B | 0.38% | 4,159,373 | 21.27B |
| 58 | ZTS | Zoetis Inc. | 29.36B | 1.11% | 4,166,868 | 9.53B |
| 59 | DGX | Quest Diagnostics Incorporated | 26.08B | -0.11% | 741,726 | 11.56B |
| 60 | WST | West Pharmaceutical Services, Inc. | 26.07B | -0.85% | 433,365 | 3.33B |
| 61 | ROIV | Roivant Sciences Ltd. | 25.86B | -0.91% | 6,764,416 | 7.53M |
| 62 | INSM | Insmed Incorporated | 25.73B | -3.06% | 2,672,745 | 1.14B |
| 63 | INCY | Incyte Corporation | 25.11B | -0.44% | 1,210,055 | 5.82B |
| 64 | LH | Labcorp Holdings Inc. | 25.11B | 0.22% | 821,526 | 14.35B |
| 65 | BNTX | BioNTech SE | 24.75B | -0.75% | 579,956 | 3.03B |
| 66 | PHG | Koninklijke Philips N.V. | 24.36B | 1.67% | 707,823 | 20.18B |
| 67 | GH | Guardant Health, Inc. | 23.79B | 0.45% | 1,578,681 | 1.18B |
| 68 | THC | Tenet Healthcare Corporation | 20.91B | 4.08% | 735,070 | 21.81B |
| 69 | GMAB | Genmab A/S | 20.74B | 1.41% | 3,583,181 | 4.13B |
| 70 | VTRS | Viatris Inc. | 20.48B | 2.35% | 10,152,775 | 14.74B |
| 71 | UTHR | United Therapeutics Corporation | 20.39B | 0.69% | 472,424 | 3.15B |
| 72 | STE | STERIS plc | 20.37B | 0.08% | 447,073 | 6.04B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.36B | 1.51% | 1,787,973 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.27B | -0.28% | 229,012 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 16.86B | 0.29% | 1,940,555 | 2.91B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.45B | 0.71% | 1,129,593 | 4.60B |
| 77 | TEM | Tempus AI, Inc. | 15.34B | 3.37% | 8,752,983 | 1.43B |
| 78 | SOLV | Solventum Corporation | 15.24B | 1.03% | 578,887 | 8.31B |
| 79 | ASND | Ascendis Pharma A/S | 14.82B | -2.21% | 419,970 | 1.20B |
| 80 | EXEL | Exelixis, Inc. | 14.41B | 0.36% | 1,989,678 | 2.44B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 14.07B | -0.39% | 1,171,038 | 3.37B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.98B | -0.54% | 838,263 | 4.00B |
| 83 | ICLR | ICON Public Limited Company | 13.30B | -0.90% | 965,904 | 8.29B |
| 84 | HALO | Halozyme Therapeutics, Inc. | 12.93B | -1.15% | 1,958,264 | 1.66B |
| 85 | BBIO | BridgeBio Pharma, Inc. | 12.82B | -1.07% | 1,998,852 | 713.07M |
| 86 | PEN | Penumbra, Inc. | 12.56B | -0.26% | 228,144 | 1.50B |
| 87 | CORT | Corcept Therapeutics Incorporated | 12.55B | -2.03% | 800,796 | 830.81M |
| 88 | SMMT | Summit Therapeutics Inc. | 12.45B | -4.70% | 3,807,975 | - |
| 89 | EHC | Encompass Health Corporation | 12.18B | 1.20% | 1,223,262 | 6.21B |
| 90 | BAX | Baxter International Inc. | 12.08B | -0.47% | 6,568,959 | 11.47B |
| 91 | FMS | Fresenius Medical Care AG | 12.02B | 1.52% | 532,836 | 22.19B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.93B | 0.65% | 153,392 | 1.28B |
| 93 | BTSG | BrightSpring Health Services, Inc. | 11.79B | 1.02% | 2,079,997 | 14.37B |
| 94 | BMRN | BioMarin Pharmaceutical Inc. | 11.66B | -1.78% | 1,791,424 | 3.41B |
| 95 | TWST | Twist Bioscience Corporation | 11.46B | -0.65% | 2,694,348 | 431.80M |
| 96 | TECH | Bio-Techne Corporation | 11.39B | 0.06% | 2,175,955 | 1.22B |
| 97 | DVA | DaVita Inc. | 11.38B | 2.18% | 519,844 | 14.01B |
| 98 | SNN | Smith & Nephew plc | 11.23B | 0.86% | 1,377,473 | 6.30B |
| 99 | TXG | 10x Genomics, Inc. | 11.17B | 1.90% | 3,393,177 | 616.91M |
| 100 | ELAN | Elanco Animal Health Incorporated | 11.15B | -0.18% | 6,454,561 | 5.02B |
| 101 | RGEN | Repligen Corporation | 10.70B | -0.51% | 1,502,364 | 785.10M |
| 102 | UHS | Universal Health Services, Inc. | 10.54B | 1.06% | 645,547 | 18.11B |
| 103 | COO | The Cooper Companies, Inc. | 10.53B | - | 4,453,970 | 4.24B |
| 104 | RDY | Dr. Reddy's Laboratories Limited | 10.45B | -0.41% | 3,168,894 | 3.50B |
| 105 | ALGN | Align Technology, Inc. | 10.43B | 0.79% | 829,594 | 4.14B |
| 106 | AVTR | Avantor, Inc. | 10.31B | -0.85% | 6,529,468 | 6.56B |
| 107 | KRYS | Krystal Biotech, Inc. | 10.24B | 0.25% | 199,918 | 440.48M |
| 108 | AXSM | Axsome Therapeutics, Inc. | 10.22B | -0.48% | 838,177 | 776.57M |
| 109 | BIO | Bio-Rad Laboratories, Inc. | 10.19B | -1.69% | 253,583 | 2.59B |
| 110 | ENSG | The Ensign Group, Inc. | 10.12B | 1.10% | 220,740 | 5.49B |
| 111 | GMED | Globus Medical, Inc. | 10.01B | 0.34% | 1,563,522 | 3.14B |
| 112 | MOH | Molina Healthcare, Inc. | 9.94B | -1.27% | 676,441 | 42.47B |
| 113 | BRKR | Bruker Corporation | 9.78B | 0.28% | 2,525,582 | 3.50B |
| 114 | HSIC | Henry Schein, Inc. | 9.63B | 0.99% | 1,202,224 | 13.60B |
| 115 | PODD | Insulet Corporation | 9.44B | 0.26% | 1,055,943 | 3.05B |
| 116 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.31B | -0.23% | 1,616,163 | 669.50M |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.31B | -3.33% | 698,433 | 105.00M |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 9.18B | 3.29% | 809,192 | 281.99M |
| 119 | QGEN | Qiagen N.V. | 9.14B | -0.85% | 1,407,971 | 2.10B |
| 120 | OSCR | Oscar Health, Inc. | 9.13B | 2.53% | 4,899,332 | 15.32B |
| 121 | GKOS | Glaukos Corporation | 9.10B | -0.29% | 826,237 | 612.84M |
| 122 | CAI | Caris Life Sciences, Inc. | 9.04B | -0.90% | 2,919,183 | 989.61M |
| 123 | CYTK | Cytokinetics, Incorporated | 8.99B | -1.52% | 1,599,215 | 67.67M |
| 124 | IBRX | ImmunityBio, Inc. | 8.95B | -2.31% | 5,819,350 | 165.79M |
| 125 | PCVX | Vaxcyte, Inc. | 8.36B | -1.21% | 947,290 | - |
| 126 | TGTX | TG Therapeutics, Inc. | 8.15B | -0.16% | 1,309,361 | 799.54M |
| 127 | ABVX | ABIVAX Société Anonyme | 8.14B | -4.02% | 1,484,591 | 5.33M |
| 128 | ATR | AptarGroup, Inc. | 7.88B | 0.40% | 325,652 | 3.93B |
| 129 | PRAX | Praxis Precision Medicines, Inc. | 7.84B | -0.36% | 456,242 | 7.46M |
| 130 | HNGE | Hinge Health, Inc. | 7.71B | 3.90% | 1,090,562 | 720.06M |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.56B | -1.61% | 560,049 | - |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.40B | 1.57% | 6,202,218 | 874.09M |
| 133 | HQY | HealthEquity, Inc. | 7.30B | -0.40% | 1,282,445 | 1.36B |
| 134 | AMRX | Amneal Pharmaceuticals, Inc. | 6.89B | -0.20% | 2,885,071 | 3.12B |
| 135 | IMVT | Immunovant, Inc. | 6.88B | -2.06% | 2,349,999 | - |
| 136 | HIMS | Hims & Hers Health, Inc. | 6.86B | 0.48% | 8,199,571 | 2.58B |
| 137 | ALKS | Alkermes plc | 6.85B | 0.15% | 2,587,336 | 1.67B |
| 138 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.79B | 0.36% | 864,251 | 239.92M |
| 139 | BLTE | Belite Bio, Inc | 6.74B | -1.25% | 123,704 | - |
| 140 | CHE | Chemed Corporation | 6.67B | 3.33% | 233,287 | 2.60B |
| 141 | PACS | PACS Group, Inc. | 6.54B | -0.39% | 549,656 | 5.55B |
| 142 | GRFS | Grifols, S.A. | 6.53B | 1.94% | 507,227 | 8.48B |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.51B | 0.02% | 952,389 | 1.56B |
| 144 | LQDA | Liquidia Corporation | 6.13B | -3.55% | 967,515 | 450.91M |
| 145 | BLCO | Bausch + Lomb Corporation | 6.02B | 0.36% | 162,103 | 5.32B |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 6.01B | 0.83% | 305,796 | 290.54M |
| 147 | CGON | CG Oncology, Inc. | 5.95B | -2.34% | 1,177,484 | 6.23M |
| 148 | SRRK | Scholar Rock Holding Corporation | 5.92B | 0.04% | 1,875,797 | - |
| 149 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.86B | -0.35% | 478,992 | 840.85M |
| 150 | MIRM | Mirum Pharmaceuticals, Inc. | 5.82B | 0.38% | 765,796 | 618.07M |
| 151 | BLLN | BillionToOne, Inc. | 5.81B | -1.46% | 528,009 | 397.41M |
| 152 | STVN | Stevanato Group S.p.A. | 5.77B | -1.17% | 286,239 | 1.40B |
| 153 | GRAL | GRAIL, Inc. | 5.67B | 1.34% | 1,292,128 | 165.26M |
| 154 | MMED | MiniMed Group, Inc. | 5.62B | -2.25% | 2,554,380 | 3.22B |
| 155 | COGT | Cogent Biosciences, Inc. | 5.61B | 2.80% | 2,979,048 | - |
| 156 | TVTX | Travere Therapeutics, Inc. | 5.60B | -1.95% | 1,205,901 | 591.33M |
| 157 | ORKA | Oruka Therapeutics, Inc. | 5.59B | -1.20% | 499,721 | - |
| 158 | RDNT | RadNet, Inc. | 5.57B | -0.73% | 598,672 | 2.27B |
| 159 | CRSP | CRISPR Therapeutics AG | 5.24B | -2.64% | 1,008,897 | 13.39M |
| 160 | SHC | Sotera Health Company | 5.23B | -0.60% | 1,247,735 | 1.22B |
| 161 | PTCT | PTC Therapeutics, Inc. | 5.23B | 0.63% | 1,203,027 | 1.01B |
| 162 | MMSI | Merit Medical Systems, Inc. | 5.22B | 0.23% | 354,045 | 1.58B |
| 163 | TFX | Teleflex Incorporated | 5.17B | 1.65% | 865,593 | 2.25B |
| 164 | ERAS | Erasca, Inc. | 4.98B | -1.86% | 3,218,053 | - |
| 165 | IOVA | Iovance Biotherapeutics, Inc. | 4.98B | 1.85% | 12,633,884 | 324.97M |
| 166 | DNTH | Dianthus Therapeutics, Inc. | 4.95B | -2.38% | 522,723 | 1.90M |
| 167 | MANE | Veradermics, Incorporated | 4.87B | 0.73% | 613,621 | - |
| 168 | DFTX | Definium Therapeutics, Inc. | 4.86B | -1.52% | 2,682,917 | - |
| 169 | HAE | Haemonetics Corporation | 4.79B | -0.66% | 492,604 | 1.35B |
| 170 | WAY | Waystar Holding Corp. | 4.74B | 0.24% | 1,260,743 | 1.21B |
| 171 | ADPT | Adaptive Biotechnologies Corporation | 4.70B | -0.47% | 1,686,001 | 308.08M |
| 172 | DOCS | Doximity, Inc. | 4.70B | 1.19% | 2,006,159 | 655.57M |
| 173 | LFST | LifeStance Health Group, Inc. | 4.52B | 0.34% | 7,827,632 | 1.58B |
| 174 | CON | Concentra Group Holdings Parent, Inc. | 4.46B | 1.13% | 571,368 | 2.29B |
| 175 | ITGR | Integer Holdings Corporation | 4.29B | 0.13% | 567,413 | 1.84B |
| 176 | HTFL | HeartFlow, Inc. | 4.28B | 1.05% | 1,159,353 | 212.07M |
| 177 | EWTX | Edgewise Therapeutics, Inc. | 4.27B | -4.42% | 2,487,516 | - |
| 178 | LIVN | LivaNova PLC | 4.22B | 1.58% | 745,304 | 1.47B |
| 179 | TNGX | Tango Therapeutics, Inc. | 4.20B | 1.18% | 3,254,999 | 53.81M |
| 180 | VKTX | Viking Therapeutics, Inc. | 4.15B | -3.24% | 13,617,271 | - |
| 181 | ICUI | ICU Medical, Inc. | 4.12B | -0.64% | 201,735 | 2.16B |
| 182 | ABCL | AbCellera Biologics Inc. | 4.12B | 0.40% | 3,383,868 | 66.17M |
| 183 | CELC | Celcuity Inc. | 3.89B | 0.19% | 657,162 | - |
| 184 | PBLS | Parabilis Medicines, Inc. | 3.85B | -3.91% | 1,119,022 | 148.00K |
| 185 | NVST | Envista Holdings Corporation | 3.85B | -0.50% | 3,245,267 | 2.86B |
| 186 | RLAY | Relay Therapeutics, Inc. | 3.83B | -1.47% | 2,983,626 | 10.35M |
| 187 | TLX | Telix Pharmaceuticals Limited | 3.79B | 1.24% | 409,202 | 890.79M |
| 188 | LEGN | Legend Biotech Corporation | 3.70B | 0.26% | 1,428,328 | 1.27B |
| 189 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.70B | -2.16% | 1,294,449 | -665.00K |
| 190 | PLSE | Pulse Biosciences, Inc. | 3.68B | -0.39% | 663,956 | 1.19M |
| 191 | VCYT | Veracyte, Inc. | 3.65B | -6.41% | 1,725,708 | 561.90M |
| 192 | IRTC | iRhythm Holdings, Inc. | 3.64B | -0.38% | 521,916 | 825.34M |
| 193 | OGN | Organon & Co. | 3.61B | 0.07% | 1,394,122 | 6.13B |
| 194 | XENE | Xenon Pharmaceuticals Inc. | 3.58B | -2.94% | 2,433,747 | 7.50M |
| 195 | ACAD | Acadia Pharmaceuticals Inc. | 3.56B | -6.76% | 3,364,113 | 1.14B |
| 196 | NHC | National HealthCare Corporation | 3.56B | 2.60% | 156,161 | 1.56B |
| 197 | IDYA | IDEAYA Biosciences, Inc. | 3.54B | - | 487,199 | 234.13M |
| 198 | OPCH | Option Care Health, Inc. | 3.46B | 0.57% | 1,168,895 | 5.69B |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.38B | 2.47% | 2,039,975 | 463.98M |
| 200 | TARS | Tarsus Pharmaceuticals, Inc. | 3.32B | -0.36% | 721,440 | 606.33M |
| 201 | WRBY | Warby Parker Inc. | 3.30B | 1.67% | 3,833,033 | 911.61M |
| 202 | CDNA | CareDx, Inc. | 3.29B | 3.76% | 2,351,007 | 458.09M |
| 203 | ELVN | Enliven Therapeutics, Inc. | 3.28B | -0.93% | 963,786 | - |
| 204 | DNLI | Denali Therapeutics Inc. | 3.26B | -0.39% | 1,257,677 | 3.60M |
| 205 | RCUS | Arcus Biosciences, Inc. | 3.18B | -0.36% | 1,717,332 | 117.00M |
| 206 | RGC | Regencell Bioscience Holdings Limited | 3.06B | - | 51,927 | - |
| 207 | NEOG | Neogen Corporation | 3.00B | 0.73% | 5,218,650 | 870.40M |
| 208 | DYN | Dyne Therapeutics, Inc. | 2.99B | -2.91% | 1,612,918 | - |
| 209 | ATRC | AtriCure, Inc. | 2.97B | -3.93% | 1,591,611 | 569.62M |
| 210 | TMDX | TransMedics Group, Inc. | 2.96B | 1.66% | 696,464 | 668.47M |
| 211 | ZLAB | Zai Lab Limited | 2.80B | -1.19% | 299,900 | 449.61M |
| 212 | PGEN | Precigen, Inc. | 2.77B | 0.65% | 6,563,526 | 85.72M |
| 213 | AVAH | Aveanna Healthcare Holdings Inc. | 2.71B | 0.24% | 2,284,745 | 2.60B |
| 214 | NAMS | NewAmsterdam Pharma Company N.V. | 2.70B | -0.70% | 1,135,990 | 7.12M |
| 215 | BKD | Brookdale Senior Living Inc. | 2.65B | 0.36% | 3,288,985 | 2.93B |
| 216 | QURE | uniQure N.V. | 2.65B | -0.23% | 1,176,583 | 18.67M |
| 217 | WGS | GeneDx Holdings Corp. | 2.64B | -0.09% | 510,259 | 454.43M |
| 218 | ACHC | Acadia Healthcare Company, Inc. | 2.62B | 1.04% | 1,150,319 | 3.37B |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.61B | -1.39% | 720,619 | 1.46B |
| 220 | MBX | MBX Biosciences, Inc. | 2.58B | -3.18% | 563,528 | - |
| 221 | GPCR | Structure Therapeutics Inc. | 2.56B | -0.25% | 1,587,795 | - |
| 222 | AXGN | Axogen, Inc. | 2.55B | 0.16% | 1,221,856 | 251.17M |
| 223 | PRVA | Privia Health Group, Inc. | 2.52B | 1.65% | 1,393,839 | 2.36B |
| 224 | IRON | Disc Medicine, Inc. | 2.50B | -1.81% | 427,231 | - |
| 225 | BFLY | Butterfly Network, Inc. | 2.50B | -0.21% | 3,747,256 | 112.14M |
| 226 | HCM | HUTCHMED (China) Limited | 2.49B | 0.79% | 71,259 | 549.12M |
| 227 | NEO | NeoGenomics, Inc. | 2.48B | -1.18% | 2,019,656 | 766.30M |
| 228 | SUPN | Supernus Pharmaceuticals, Inc. | 2.48B | -1.46% | 607,568 | 830.44M |
| 229 | CLDX | Celldex Therapeutics, Inc. | 2.44B | -1.21% | 2,023,886 | 158.00K |
| 230 | IMNM | Immunome, Inc. | 2.43B | -4.16% | 2,421,626 | 4.02M |
| 231 | BEAM | Beam Therapeutics Inc. | 2.43B | -1.58% | 1,219,342 | 156.04M |
| 232 | HRMY | Harmony Biosciences Holdings, Inc. | 2.40B | 0.24% | 556,855 | 959.90M |
| 233 | NRIX | Nurix Therapeutics, Inc. | 2.39B | -2.71% | 1,540,070 | 36.77M |
| 234 | CLOV | Clover Health Investments, Corp. | 2.38B | -0.44% | 3,605,896 | 2.48B |
| 235 | TRLV | Trulieve Cannabis Corp. | 2.35B | -0.49% | 1,011,456 | 1.14B |
| 236 | VERA | Vera Therapeutics, Inc. | 2.34B | -2.40% | 1,250,478 | - |
| 237 | SLS | SELLAS Life Sciences Group, Inc. | 2.34B | -3.09% | 4,452,916 | - |
| 238 | VRDN | Viridian Therapeutics, Inc. | 2.32B | -0.92% | 2,090,645 | 71.13M |
| 239 | UFPT | UFP Technologies, Inc. | 2.29B | -0.95% | 72,256 | 631.64M |
| 240 | MLYS | Mineralys Therapeutics, Inc. | 2.29B | -2.75% | 1,192,717 | - |
| 241 | ALMR | Alamar Biosciences, Inc. | 2.28B | -1.20% | 297,265 | 100.42M |
| 242 | PHVS | Pharvaris N.V. | 2.25B | -2.94% | 597,497 | - |
| 243 | PBH | Prestige Consumer Healthcare Inc. | 2.21B | 2.10% | 467,652 | 1.10B |
| 244 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.20B | 0.82% | 3,666,444 | 940.61M |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.19B | -0.96% | 734,401 | 311.51M |
| 246 | SDGR | Schrödinger, Inc. | 2.16B | -2.04% | 1,369,824 | 259.04M |
| 247 | PRGO | Perrigo Company plc | 2.14B | 5.04% | 4,279,730 | 4.14B |
| 248 | BHC | Bausch Health Companies Inc. | 2.13B | 0.71% | 1,250,371 | 10.85B |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.12B | -1.73% | 1,621,483 | 52.06M |
| 250 | ADMA | ADMA Biologics, Inc. | 2.10B | -1.47% | 3,566,524 | 512.28M |
| 251 | MD | Pediatrix Medical Group, Inc. | 2.09B | 2.53% | 386,030 | 1.95B |
| 252 | ADUS | Addus HomeCare Corporation | 2.07B | -0.75% | 216,541 | 1.48B |
| 253 | ADRX | ADARx Pharmaceuticals, Inc. | 2.06B | 13.82% | 4,213,818 | 6.13M |
| 254 | TRVI | Trevi Therapeutics, Inc. | 2.05B | -1.84% | 1,364,962 | - |
| 255 | ALVO | Alvotech | 2.05B | -2.21% | 705,130 | 494.61M |
| 256 | INSP | Inspire Medical Systems, Inc. | 2.04B | 2.46% | 609,843 | 898.74M |
| 257 | VCEL | Vericel Corporation | 2.03B | 1.04% | 359,896 | 306.30M |
| 258 | KOD | Kodiak Sciences Inc. | 2.03B | -2.62% | 2,277,335 | - |
| 259 | URGN | UroGen Pharma Ltd. | 2.02B | 0.29% | 655,313 | 188.73M |
| 260 | NUVB | Nuvation Bio Inc. | 2.02B | 0.17% | 2,817,201 | 169.90M |
| 261 | RXRX | Recursion Pharmaceuticals, Inc. | 2.01B | -3.86% | 10,481,051 | 54.86M |
| 262 | PVLA | Palvella Therapeutics, Inc. | 1.99B | -5.42% | 193,341 | - |
| 263 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.97B | -0.65% | 1,930,861 | 208.78M |
| 264 | SRPT | Sarepta Therapeutics, Inc. | 1.97B | 1.52% | 2,218,839 | 1.97B |
| 265 | MESO | Mesoblast Limited | 1.97B | -2.33% | 126,080 | 120.25M |
| 266 | ESTA | Establishment Labs Holdings Inc. | 1.97B | 0.59% | 264,990 | 245.82M |
| 267 | BHVN | Biohaven Ltd. | 1.96B | -1.52% | 1,579,106 | - |
| 268 | PGNY | Progyny, Inc. | 1.95B | -2.04% | 1,110,665 | 1.31B |
| 269 | NKTR | Nektar Therapeutics | 1.95B | -3.91% | 2,636,128 | 54.59M |
| 270 | AGIO | Agios Pharmaceuticals, Inc. | 1.95B | -0.97% | 996,512 | 98.34M |
| 271 | GENB | Generate Biomedicines, Inc. | 1.94B | -5.25% | 1,266,989 | 26.48M |
| 272 | LKFT | Lakefront Biotherapeutics NV | 1.92B | -3.23% | 250,700 | 1.13B |
| 273 | FTRE | Fortrea Holdings Inc. | 1.89B | -0.65% | 708,894 | 2.68B |
| 274 | BLFS | BioLife Solutions, Inc. | 1.88B | -0.23% | 998,549 | 106.69M |
| 275 | ZYME | Zymeworks Inc. | 1.88B | -1.08% | 1,094,727 | 37.13M |
| 276 | XRAY | DENTSPLY SIRONA Inc. | 1.87B | -1.36% | 4,894,992 | 3.64B |
| 277 | SGRY | Surgery Partners, Inc. | 1.87B | 1.41% | 1,762,754 | 3.37B |
| 278 | LMAT | LeMaitre Vascular, Inc. | 1.86B | 0.87% | 230,349 | 262.43M |
| 279 | ASTH | Astrana Health, Inc. | 1.86B | 5.60% | 336,606 | 3.84B |
| 280 | NVCR | NovoCure Limited | 1.84B | -2.22% | 1,027,950 | 699.19M |
| 281 | CMPS | COMPASS Pathways plc | 1.81B | -0.23% | 2,229,084 | - |
| 282 | VIR | Vir Biotechnology, Inc. | 1.80B | -0.56% | 1,125,948 | 303.23M |
| 283 | SNDA | Sonida Senior Living, Inc. | 1.79B | 0.43% | 388,553 | 481.07M |
| 284 | XNCR | Xencor, Inc. | 1.77B | -0.34% | 1,169,669 | 104.97M |
| 285 | SEPN | Septerna, Inc. | 1.76B | -0.94% | 344,294 | 98.88M |
| 286 | PSNL | Personalis, Inc. | 1.76B | -0.66% | 1,016,100 | 69.67M |
| 287 | ZBIO | Zenas BioPharma, Inc. | 1.76B | -2.00% | 747,843 | 1.00M |
| 288 | NVAX | Novavax, Inc. | 1.75B | 0.28% | 3,910,299 | 413.80M |
| 289 | FRNM | Freenome, Inc. | 1.72B | -0.12% | 418,837 | 35.41M |
| 290 | ALHC | Alignment Healthcare, Inc. | 1.70B | 7.04% | 10,703,836 | 4.58B |
| 291 | NBTX | Nanobiotix S.A. | 1.69B | -0.45% | 124,575 | 13.15M |
| 292 | ABSI | Absci Corporation | 1.67B | -5.89% | 3,206,563 | 1.56M |
| 293 | XERS | Xeris Biopharma Holdings, Inc. | 1.66B | 1.68% | 1,546,923 | 335.41M |
| 294 | ETON | Eton Pharmaceuticals, Inc. | 1.65B | -3.04% | 514,394 | 105.60M |
| 295 | NTLA | Intellia Therapeutics, Inc. | 1.65B | -3.37% | 2,985,547 | 59.51M |
| 296 | GHRS | GH Research PLC | 1.64B | -2.49% | 179,976 | - |
| 297 | RAPP | Rapport Therapeutics, Inc. | 1.63B | 0.24% | 711,805 | 20.00M |
| 298 | SNDX | Syndax Pharmaceuticals, Inc. | 1.63B | 1.28% | 1,343,101 | 252.25M |
| 299 | COAG | Hemab Therapeutics Holdings, Inc. | 1.62B | -2.74% | 266,529 | - |
| 300 | KMTS | Kestra Medical Technologies, Ltd. | 1.62B | 5.36% | 339,689 | 106.73M |
| 301 | STOK | Stoke Therapeutics, Inc. | 1.60B | -1.94% | 1,218,091 | 27.59M |
| 302 | ANIP | ANI Pharmaceuticals, Inc. | 1.59B | -0.05% | 278,678 | 978.38M |
| 303 | IMCR | Immunocore Holdings plc | 1.58B | -1.82% | 271,894 | 430.78M |
| 304 | ATEC | Alphatec Holdings, Inc. | 1.56B | 2.02% | 3,003,817 | 815.05M |
| 305 | OMCL | Omnicell, Inc. | 1.54B | 1.91% | 508,701 | 1.25B |
| 306 | ANAB | AnaptysBio, Inc. | 1.52B | -1.35% | 437,400 | 106.09M |
| 307 | TSHA | Taysha Gene Therapies, Inc. | 1.52B | -2.51% | 4,660,849 | 5.49M |
| 308 | NUTX | Nutex Health Inc. | 1.51B | 7.59% | 211,235 | 846.72M |
| 309 | INVA | Innoviva, Inc. | 1.50B | 0.44% | 623,372 | 440.00M |
| 310 | TYRA | Tyra Biosciences, Inc. | 1.50B | -2.90% | 1,421,982 | - |
| 311 | AZTA | Azenta, Inc. | 1.49B | -0.53% | 781,096 | 613.81M |
| 312 | ARDT | Ardent Health, Inc. | 1.49B | 0.57% | 251,878 | 6.41B |
| 313 | INBX | Inhibrx Biosciences, Inc. | 1.47B | -0.79% | 158,658 | 1.30M |
| 314 | KLRA | Kailera Therapeutics, Inc. | 1.45B | -6.39% | 1,722,736 | - |
| 315 | OMER | Omeros Corporation | 1.45B | -0.25% | 941,896 | 38.42M |
| 316 | MAZE | Maze Therapeutics, Inc. | 1.45B | -0.61% | 925,606 | 20.00M |
| 317 | HCSG | Healthcare Services Group, Inc. | 1.44B | 0.38% | 400,649 | 1.86B |
| 318 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | -1.83% | 4,306,057 | 717.00M |
| 319 | PNTG | The Pennant Group, Inc. | 1.42B | 2.88% | 421,823 | 1.10B |
| 320 | KRSA | Korsana Biosciences, Inc. | 1.41B | -16.64% | 34,777 | - |
| 321 | AVBP | ArriVent BioPharma, Inc. | 1.40B | -5.48% | 653,151 | - |
| 322 | PAHC | Phibro Animal Health Corporation | 1.40B | 1.50% | 206,581 | 1.52B |
| 323 | CERT | Certara, Inc. | 1.39B | 2.47% | 2,915,618 | 421.75M |
| 324 | KARD | Kardigan, Inc. | 1.38B | 2.78% | 628,912 | - |
| 325 | ORIC | ORIC Pharmaceuticals, Inc. | 1.36B | -0.15% | 2,493,809 | - |
| 326 | CNMD | CONMED Corporation | 1.36B | 0.44% | 282,595 | 1.37B |
| 327 | AGL | agilon health, inc. | 1.36B | 6.46% | 283,734 | 5.92B |
| 328 | AAPG | Ascentage Pharma Group International | 1.36B | -2.46% | 2,864 | 94.61M |
| 329 | BRVE | Braveheart Bio, Inc. | 1.35B | -11.77% | 471,826 | - |
| 330 | DRTS | Alpha Tau Medical Ltd. | 1.34B | -1.56% | 435,363 | - |
| 331 | AMN | AMN Healthcare Services, Inc. | 1.34B | - | 463,442 | 3.43B |
| 332 | DMRA | Damora Therapeutics, Inc. | 1.28B | 1.92% | 1,431,775 | - |
| 333 | BCAX | Bicara Therapeutics Inc. | 1.27B | -2.88% | 662,512 | - |
| 334 | SVRA | Savara Inc. | 1.27B | -1.38% | 2,451,630 | - |
| 335 | USPH | U.S. Physical Therapy, Inc. | 1.27B | 1.29% | 130,578 | 804.27M |
| 336 | IART | Integra LifeSciences Holdings Corporation | 1.25B | 1.51% | 539,024 | 1.65B |
| 337 | AVLN | Avalyn Pharma Inc. | 1.24B | -1.65% | 223,122 | - |
| 338 | HROW | Harrow, Inc. | 1.24B | -0.09% | 372,953 | 275.59M |
| 339 | CRON | Cronos Group Inc. | 1.24B | 0.60% | 876,478 | 179.09M |
| 340 | TRAX | First Tracks Biotherapeutics, Inc. | 1.23B | -3.94% | 356,510 | - |
| 341 | INNV | InnovAge Holding Corp. | 1.23B | 1.81% | 1,544,300 | 989.71M |
| 342 | OPK | OPKO Health, Inc. | 1.22B | - | 1,531,347 | 587.90M |
| 343 | LBRX | LB Pharmaceuticals Inc | 1.20B | -1.24% | 398,941 | - |
| 344 | OMDA | Omada Health, Inc. | 1.20B | -0.30% | 873,664 | 309.76M |
| 345 | REPL | Replimune Group, Inc. | 1.16B | -1.90% | 1,647,235 | - |
| 346 | BVS | Bioventus Inc. | 1.16B | 2.14% | 454,762 | 581.85M |
| 347 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 1.89% | 192,796 | - |
| 348 | IMTX | Immatics N.V. | 1.14B | 0.48% | 378,808 | 47.65M |
| 349 | GDRX | GoodRx Holdings, Inc. | 1.14B | -0.30% | 508,908 | 785.23M |
| 350 | LTGO | Latigo Biotherapeutics, Inc. | 1.14B | -3.43% | 275,688 | - |
| 351 | BBNX | Beta Bionics, Inc. | 1.13B | -1.15% | 926,004 | 119.01M |
| 352 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.11B | -0.53% | 376,921 | 730.02M |
| 353 | TDOC | Teladoc Health, Inc. | 1.11B | -0.81% | 3,027,003 | 2.49B |
| 354 | AORT | Artivion, Inc. | 1.10B | -1.74% | 502,762 | 471.47M |
| 355 | IRMD | IRADIMED CORPORATION | 1.10B | 0.66% | 146,428 | 86.34M |
| 356 | VOR | Vor Biopharma Inc. | 1.10B | 0.43% | 792,829 | - |
| 357 | CSTL | Castle Biosciences, Inc. | 1.09B | 1.76% | 437,681 | 357.28M |
| 358 | TNDM | Tandem Diabetes Care, Inc. | 1.09B | 3.29% | 2,839,698 | 1.04B |
| 359 | AKTS | Aktis Oncology, Inc. | 1.08B | -1.02% | 518,910 | 10.06M |
| 360 | MNKD | MannKind Corporation | 1.07B | 1.52% | 8,853,613 | 393.63M |
| 361 | ENOV | Enovis Corporation | 1.06B | 1.04% | 1,289,103 | 2.30B |
| 362 | MGTX | MeiraGTx Holdings plc | 1.05B | -1.27% | 1,555,566 | 397.50M |
| 363 | ANRO | Alto Neuroscience, Inc. | 1.04B | -2.54% | 366,263 | - |
| 364 | STAA | STAAR Surgical Company | 1.03B | 7.49% | 1,309,277 | 339.59M |
| 365 | MLTX | MoonLake Immunotherapeutics | 1.02B | -0.66% | 2,179,618 | - |
| 366 | GLUE | Monte Rosa Therapeutics, Inc. | 1.00B | 0.43% | 802,136 | 28.73M |
| 367 | PCRX | Pacira BioSciences, Inc. | 1.00B | -1.72% | 444,230 | 746.16M |
| 368 | ANL | Adlai Nortye Group Ltd. | 1.00B | -0.88% | 34,799 | 18.06M |
| 369 | JANX | Janux Therapeutics, Inc. | 996.53M | -2.28% | 720,162 | 24.00M |
| 370 | PRCT | PROCEPT BioRobotics Corporation | 985.11M | -1.71% | 1,954,201 | 337.34M |
| 371 | ODTX | Odyssey Therapeutics, Inc. | 982.81M | 2.91% | 237,781 | 99.00K |
| 372 | LMRI | Lumexa Imaging Holdings, Inc. | 980.93M | 3.34% | 441,199 | 1.04B |
| 373 | CRVS | Corvus Pharmaceuticals, Inc. | 977.49M | -1.53% | 1,099,643 | - |
| 374 | ABUS | Arbutus Biopharma Corporation | 959.56M | -0.61% | 16,881,131 | 181.72M |
| 375 | KURA | Kura Oncology, Inc. | 957.22M | -0.92% | 1,226,674 | 77.23M |
| 376 | CGEM | Cullinan Therapeutics, Inc. | 953.09M | -4.08% | 1,715,490 | - |
| 377 | HELP | Cybin Inc. | 921.29M | 0.16% | 805,498 | - |
| 378 | ALMS | Alumis Inc. | 918.99M | -2.61% | 1,723,930 | 7.40M |
| 379 | JBIO | Jade Biosciences, Inc. | 917.07M | -2.10% | 525,819 | - |
| 380 | CBLL | CeriBell, Inc. | 909.18M | -0.55% | 270,546 | 101.96M |
| 381 | SGP | SpyGlass Pharma, Inc. | 905.44M | -2.10% | 96,408 | - |
| 382 | RIGL | Rigel Pharmaceuticals, Inc. | 900.00M | 0.61% | 204,927 | 276.79M |
| 383 | SLBT | SL Science Holding Limited | 895.32M | 0.64% | 286,681 | 3.27M |
| 384 | HSTM | HealthStream, Inc. | 890.34M | 0.80% | 196,376 | 321.12M |
| 385 | SANA | Sana Biotechnology, Inc. | 881.62M | -0.51% | 2,880,332 | - |
| 386 | APMD | Apnimed, Inc. | 877.99M | -2.50% | 298,550 | 115.12M |
| 387 | GMRS | GMR Solutions Inc. | 859.60M | 2.79% | 645,627 | 5.88B |
| 388 | ARDX | Ardelyx, Inc. | 852.22M | -0.87% | 2,126,078 | 450.89M |
| 389 | CADL | Candel Therapeutics, Inc. | 843.23M | -4.59% | 799,697 | - |
| 390 | SIBN | SI-BONE, Inc. | 833.18M | 0.38% | 625,836 | 213.60M |
| 391 | AVTX | Avalo Therapeutics, Inc. | 829.66M | -1.59% | 1,433,791 | 59.00K |
| 392 | INMD | InMode Ltd. | 819.68M | 0.49% | 412,411 | 374.63M |
| 393 | ATTO | Attovia Therapeutics, Inc. | 811.68M | -2.15% | 404,431 | 1.80M |
| 394 | GERN | Geron Corporation | 809.52M | - | 10,302,741 | 204.56M |
| 395 | FDMT | 4D Molecular Therapeutics, Inc. | 799.38M | -1.63% | 1,017,950 | 92.01M |
| 396 | LXRX | Lexicon Pharmaceuticals, Inc. | 798.70M | -3.49% | 3,050,414 | 41.47M |
| 397 | OBX | Obsidian Therapeutics, Inc. | 794.40M | -4.10% | 454,476 | - |
| 398 | IMMX | Immix Biopharma, Inc. | 784.79M | -6.24% | 1,828,421 | - |
| 399 | SLDB | Solid Biosciences Inc. | 781.67M | -2.54% | 1,420,481 | - |
| 400 | GYRE | Gyre Therapeutics, Inc. | 779.35M | 0.27% | 134,831 | 109.82M |
| 401 | VREX | Varex Imaging Corporation | 777.63M | -0.11% | 569,425 | 865.00M |
| 402 | ACHV | Achieve Life Sciences, Inc. | 775.88M | -3.70% | 1,422,933 | - |
| 403 | IVA | Inventiva S.A. | 766.06M | 3.37% | 2,998,590 | 7.94M |
| 404 | OLMA | Olema Pharmaceuticals, Inc. | 765.60M | -3.21% | 1,382,733 | - |
| 405 | DSGN | Design Therapeutics, Inc. | 758.49M | -0.98% | 434,470 | - |
| 406 | ACRS | Aclaris Therapeutics, Inc. | 758.07M | -4.28% | 1,474,036 | 8.22M |
| 407 | AHCO | AdaptHealth Corp. | 752.43M | 1.26% | 1,354,334 | 3.36B |
| 408 | QDEL | QuidelOrtho Corporation | 750.22M | 2.34% | 1,379,771 | 2.67B |
| 409 | AVR | Anteris Technologies Global Corp. | 749.46M | 0.52% | 762,663 | 2.24M |
| 410 | PHAR | Pharming Group N.V. | 747.87M | 0.19% | 128,516 | 366.48M |
| 411 | WVE | Wave Life Sciences, Inc. | 744.84M | -4.55% | 4,066,700 | 65.37M |
| 412 | CTKB | Cytek Biosciences, Inc. | 734.41M | -1.40% | 1,494,810 | 206.71M |
| 413 | COLL | Collegium Pharmaceutical, Inc. | 733.48M | -0.49% | 503,427 | 808.21M |
| 414 | ETRA | Electra Therapeutics, Inc. | 724.96M | -2.28% | 438,362 | - |
| 415 | FTH | Faeth Therapeutics, Inc. | 723.53M | -3.61% | 328,188 | - |
| 416 | DNA | Ginkgo Bioworks Holdings, Inc. | 717.85M | 4.00% | 2,312,318 | 132.42M |
| 417 | SOPH | SOPHiA GENETICS SA | 709.97M | 0.97% | 519,731 | 86.17M |
| 418 | VSTM | Verastem, Inc. | 700.96M | -0.77% | 1,061,072 | 87.53M |
| 419 | ANNX | Annexon, Inc. | 690.07M | -4.21% | 3,510,757 | - |
| 420 | IRWD | Ironwood Pharmaceuticals, Inc. | 682.44M | -1.43% | 1,319,655 | 389.32M |
| 421 | DBVT | DBV Technologies S.A. | 681.87M | -0.34% | 289,997 | 5.04M |
| 422 | MDXG | MiMedx Group, Inc. | 680.70M | -0.85% | 1,460,099 | 355.17M |
| 423 | STLN | Starling Oncology, Inc. | 678.76M | 2.30% | 1,127,151 | 587.24M |
| 424 | SLN | Silence Therapeutics plc | 673.14M | -0.36% | 953,220 | 615.00K |
| 425 | OABI | OmniAb, Inc. | 670.25M | -3.76% | 783,590 | 38.46M |
| 426 | CLYM | Climb Bio, Inc. | 669.71M | -1.93% | 1,532,843 | - |
| 427 | NVCT | Nuvectis Pharma, Inc. | 658.80M | -6.52% | 191,813 | - |
| 428 | ZVRA | Zevra Therapeutics, Inc. | 655.60M | -1.95% | 678,556 | 136.07M |
| 429 | AHG | Akso Health Group | 642.53M | -1.32% | 2,398 | 13.83M |
| 430 | GLAS | Glass House Brands Inc. | 640.85M | -4.90% | 1,817,348 | 176.98M |
| 431 | ANGO | AngioDynamics, Inc. | 640.24M | 1.37% | 635,480 | 320.17M |
| 432 | PHR | Phreesia, Inc. | 630.02M | 1.50% | 757,838 | 507.79M |
| 433 | BLSM | BlossomHill Therapeutics, Inc. | 627.75M | -3.52% | 203,053 | - |
| 434 | AURA | Aura Biosciences, Inc. | 622.23M | -2.44% | 1,116,376 | - |
| 435 | CRMD | CorMedix Inc. | 611.86M | 1.03% | 606,642 | 462.25M |
| 436 | FLGT | Fulgent Genetics, Inc. | 610.84M | 3.02% | 246,959 | 323.93M |
| 437 | STTK | Shattuck Labs, Inc. | 609.20M | -3.80% | 893,670 | 1.00M |
| 438 | CBIO | Crescent Biopharma, Inc. | 598.79M | -1.76% | 228,645 | 11.88M |
| 439 | ALT | Altimmune, Inc. | 595.22M | 0.66% | 2,859,131 | 31.00K |
| 440 | SSII | SS Innovations International, Inc. | 591.14M | - | 56,141 | 52.40M |
| 441 | KIDS | OrthoPediatrics Corp. | 588.78M | -0.40% | 125,288 | 252.72M |
| 442 | CTMX | CytomX Therapeutics, Inc. | 588.33M | -1.82% | 3,031,502 | 18.30M |
| 443 | WEAV | Weave Communications, Inc. | 587.99M | 0.14% | 1,899,027 | 257.79M |
| 444 | AQST | Aquestive Therapeutics, Inc. | 587.39M | -2.90% | 1,910,386 | 54.09M |
| 445 | MPLT | MapLight Therapeutics, Inc. | 581.32M | -2.79% | 317,495 | - |
| 446 | PHAT | Phathom Pharmaceuticals, Inc. | 579.84M | 3.11% | 1,442,495 | 239.66M |
| 447 | VALN | Valneva SE | 574.88M | -1.29% | 15,036 | 163.30M |
| 448 | SGMT | Sagimet Biosciences Inc. | 574.35M | 1.43% | 1,246,944 | - |
| 449 | OCS | Oculis Holding AG | 572.26M | -1.49% | 239,582 | 1.45M |
| 450 | MNPR | Monopar Therapeutics Inc. | 572.11M | -4.06% | 105,822 | - |
| 451 | ALLO | Allogene Therapeutics, Inc. | 570.06M | -1.20% | 3,622,311 | 4.64M |
| 452 | EVO | Evotec SE | 569.20M | 1.96% | 20,532 | 819.47M |
| 453 | NGNE | Neurogene Inc. | 566.52M | -9.41% | 200,066 | 925.00K |
| 454 | TLRY | Tilray Brands, Inc. | 565.78M | 1.47% | 2,137,815 | 915.45M |
| 455 | DCTH | Delcath Systems, Inc. | 541.30M | -2.99% | 262,282 | 95.42M |
| 456 | SENS | Senseonics Holdings, Inc. | 528.74M | -3.29% | 569,757 | 48.55M |
| 457 | CERS | Cerus Corporation | 528.00M | 0.38% | 2,672,811 | 221.55M |
| 458 | BWAY | BrainsWay Ltd. | 527.37M | 0.76% | 54,525 | 60.70M |
| 459 | EPRX | Eupraxia Pharmaceuticals Inc. | 527.23M | -1.84% | 1,313,299 | - |
| 460 | EOLS | Evolus, Inc. | 526.42M | 1.40% | 398,309 | 316.49M |
| 461 | AGMB | AgomAb Therapeutics NV | 517.60M | -0.66% | 164,025 | - |
| 462 | PRME | Prime Medicine, Inc. | 515.92M | -5.54% | 7,116,280 | 4.07M |
| 463 | DRUG | Bright Minds Biosciences Inc. | 515.74M | -3.20% | 210,970 | - |
| 464 | TCMD | Tactile Systems Technology, Inc. | 514.89M | -0.70% | 264,660 | 350.31M |
| 465 | INDP | Indaptus Therapeutics, Inc. | 512.98M | -3.75% | 570,879 | - |
| 466 | KMDA | Kamada Ltd. | 504.49M | -1.25% | 92,044 | 191.85M |
| 467 | PBYI | Puma Biotechnology, Inc. | 504.33M | -0.51% | 261,775 | 231.24M |
| 468 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 469 | PACB | Pacific Biosciences of California, Inc. | 503.55M | 2.53% | 11,367,889 | 159.27M |
| 470 | TKNO | Alpha Teknova, Inc. | 500.91M | 0.43% | 291,801 | 43.70M |
| 471 | ARVN | Arvinas, Inc. | 496.28M | -2.57% | 713,342 | 316.70M |
| 472 | AUTL | Autolus Therapeutics plc | 493.73M | -2.88% | 1,383,511 | 117.39M |
| 473 | SGHT | Sight Sciences, Inc. | 491.94M | 2.88% | 353,461 | 83.38M |
| 474 | RGNX | REGENXBIO Inc. | 488.50M | 2.21% | 1,276,586 | 174.48M |
| 475 | CAPR | Capricor Therapeutics, Inc. | 486.04M | -2.45% | 1,919,489 | 11.13M |
| 476 | PROK | ProKidney Corp. | 483.72M | -4.76% | 2,166,921 | 818.00K |
| 477 | NPCE | NeuroPace, Inc. | 482.60M | 0.64% | 231,406 | 106.99M |
| 478 | ASMB | Assembly Biosciences, Inc. | 481.94M | 0.04% | 143,516 | 74.85M |
| 479 | ENTX | Entera Bio Ltd. | 475.27M | -1.96% | 776,301 | 42.00K |
| 480 | MASS | 908 Devices Inc. | 472.86M | -0.69% | 303,906 | 60.84M |
| 481 | CTNM | Contineum Therapeutics, Inc. | 472.52M | 0.72% | 404,929 | - |
| 482 | SRTA | Strata Critical Medical, Inc. | 471.53M | 1.14% | 519,606 | 255.98M |
| 483 | OVID | Ovid Therapeutics Inc. | 468.71M | -3.81% | 1,364,814 | 1.58M |
| 484 | TECX | Tectonic Therapeutic, Inc. | 462.73M | -1.87% | 97,046 | - |
| 485 | CLPT | ClearPoint Neuro, Inc. | 452.38M | 1.51% | 321,306 | 42.28M |
| 486 | NRC | NRC Health | 432.88M | -3.07% | 139,182 | 140.00M |
| 487 | EIKN | Eikon Therapeutics, Inc. | 428.99M | -4.46% | 377,185 | - |
| 488 | DMAC | DiaMedica Therapeutics Inc. | 428.17M | 1.40% | 236,352 | - |
| 489 | PRTA | Prothena Corporation plc | 425.58M | -0.22% | 481,047 | 54.53M |
| 490 | KYTX | Kyverna Therapeutics, Inc. | 421.15M | -2.58% | 1,503,217 | - |
| 491 | AVIR | Atea Pharmaceuticals, Inc. | 414.66M | - | 280,666 | - |
| 492 | CARL | Carlsmed, Inc. | 412.27M | 1.89% | 65,417 | 63.30M |
| 493 | RZLT | Rezolute, Inc. | 409.10M | -1.02% | 2,046,745 | - |
| 494 | RLMD | Relmada Therapeutics, Inc. | 408.55M | 0.52% | 1,311,049 | - |
| 495 | EVH | Evolent Health, Inc. | 408.14M | 2.56% | 2,990,330 | 2.10B |
| 496 | YDES | YD Bio Limited | 405.86M | 20.13% | 656,541 | 1.24M |
| 497 | SPRY | ARS Pharmaceuticals, Inc. | 405.75M | -1.69% | 1,035,223 | 116.93M |
| 498 | SCTX | Scribe Therapeutics Inc. | 402.87M | -1.53% | 458,653 | 33.30M |
| 499 | CGC | Canopy Growth Corporation | 400.95M | 1.35% | 1,061,002 | 206.77M |
| 500 | PRLD | Prelude Therapeutics Incorporated | 399.11M | -2.88% | 336,231 | 22.42M |